Search all trials

Find therapies in clinical trials near you – page 9

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Breast cancer+2

Not recruiting

InvestigationalNo placebo

A Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Disitamab Vedotin

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Long-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer

Registered drugNo placebo

Greece

Participants:18–64 years · 65+ years
Substances:Goserelin Acetate

Contact Research Centre

Breast cancer+7

Not recruiting

InvestigationalNo placebo

Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Bemarituzumab

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Study of 89Zr-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Trastuzumab

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drug

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Registered drug

Austria

Participants:18–64 years · Healthy volunteers
Substances:Denosumab

Contact Research Centre

Breast cancer+3

Not recruiting

InvestigationalNo placebo

Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

InvestigationalNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:ZELENECTIDE PEVEDOTIN

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Talazoparib for Advanced Breast Cancer Patients Using the RECAP Test

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Talazoparib

Contact Research Centre

Breast cancer

Not recruiting

Registered drugNo placebo

Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

Registered drugNo placebo

Norway

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Breast cancer+4

Not recruiting

Registered drugNo placebo

Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Breast cancer+2

Not recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

Registered drugNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Fulvestrant

Contact Research Centre

Find therapies in clinical trials near you – page 9

168 trials match your criteria

Breast cancer+2

A Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer

Breast cancer+1

Long-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer

Breast cancer+7

Study of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein

Breast cancer+2

Study of 89Zr-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer

Breast cancer+2

Study on Denosumab to Prevent Breast Cancer in Women with BRCA1 Mutation

Breast cancer+3

Study of BT8009 for Patients with Advanced Breast Cancer with NECTIN4 Amplification

Breast cancer+1

Study of PF-07220060 and Letrozole for Adults with HR-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Breast cancer

Study on Chemotherapy and Aromatase Inhibitors (Exemestane, Letrozole, Anastrozole) for Post-Menopausal Patients with Early Breast Cancer

Breast cancer

Study on Talazoparib for Advanced Breast Cancer Patients Using the RECAP Test

Breast cancer

Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

Breast cancer+4

Study of Pembrolizumab and Olaparib for Patients with Advanced HER2 Negative Breast Cancer and Specific Genetic Mutations

Breast cancer+2

Study on the Safety and Effectiveness of PF-07104091 Alone or with Fulvestrant, Letrozole, and Palbociclib for Patients with Advanced Breast, Ovarian, or Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.